Literature DB >> 27684358

Behcet's syndrome in nonendemic regions.

Pietro Leccese1, Yusuf Yazici, Ignazio Olivieri.   

Abstract

PURPOSE OF REVIEW: Behcet's syndrome is more common in certain geographic regions, however, can be seen outside of these areas and need to be included in the differential diagnosis of many patients, as it has overlapping features with many rheumatologic conditions. RECENT
FINDINGS: Especially in regions with immigrant populations, there seem to be similarities to originating countries in Behcet's prevalence, but the syndrome is not limited to those from certain backgrounds and can be seen in others also. There is emerging evidence that even though the prevalence of Behcet's may be similar to that of endemic areas, in nonendemic regions the condition may be less severe, suggesting potential environment agents in determining the severity of the disease. In addition, women seem to be overrepresented in nonendemic areas and may explain part of the reason for less severe symptoms, as Behcet's tends to be more severe in men.
SUMMARY: The somewhat different presentation of Behcet's syndrome in nonendemic areas needs to be considered when thinking about Behcet's in the differential diagnosis of patients. Research into potentially less severe form of the disease in nonendemic areas may provide new clues to the pathogenesis of this condition.

Entities:  

Mesh:

Year:  2017        PMID: 27684358     DOI: 10.1097/BOR.0000000000000349

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  9 in total

1.  Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.

Authors:  Claudia Fabiani; Antonio Vitale; Donato Rigante; Giacomo Emmi; Giuseppe Lopalco; Jurgen Sota; Lorenzo Vannozzi; Gerardo di Scala; Silvana Guerriero; Ida Orlando; Rossella Franceschini; Marco Capozzoli; Bruno Frediani; Mauro Galeazzi; Florenzo Iannone; Gian Marco Tosi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2018-04-18       Impact factor: 2.980

Review 2.  Behçet's Syndrome and Nervous System Involvement.

Authors:  Uğur Uygunoğlu; Aksel Siva
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

Review 3.  Phenotypes in Behçet's syndrome.

Authors:  Emire Seyahi
Journal:  Intern Emerg Med       Date:  2019-02-11       Impact factor: 3.397

4.  Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet's syndrome patients: a preliminary case-control study.

Authors:  Maria Carmela Padula; Pietro Leccese; Emanuela Pellizzieri; Angela Anna Padula; Michele Gilio; Teresa Carbone; Nancy Lascaro; Giuseppina Tramontano; Giuseppe Martelli; Salvatore D'Angelo
Journal:  Intern Emerg Med       Date:  2019-02-28       Impact factor: 3.397

5.  Rare esophageal ulcers related to Behçet disease: A case report.

Authors:  Ning Jia; Yanping Tang; Huayi Liu; Yang Li; Simiao Liu; Lei Liu
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

6.  New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.

Authors:  Anna Santarsiero; Pietro Leccese; Paolo Convertini; Angela Padula; Paolo Abriola; Salvatore D'Angelo; Faustino Bisaccia; Vittoria Infantino
Journal:  Mediators Inflamm       Date:  2018-06-28       Impact factor: 4.711

7.  Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet's disease in the Shanghai Adamantiades-Behçet's disease database: a prospective cohort study.

Authors:  Liang Zhang; Yun Tian; Jing-Fen Ye; Chen-Hong Lin; Jian-Long Guan
Journal:  Orphanet J Rare Dis       Date:  2019-11-28       Impact factor: 4.123

Review 8.  Coronary Involvement in Behçet's Disease: what are its Risks and Prognosis? (Rare Cases and Literature Review).

Authors:  Unsal Vural; Mehmet Kizilay; Ahmet Arif Aglar
Journal:  Braz J Cardiovasc Surg       Date:  2019-12-01

Review 9.  Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases.

Authors:  Carla Gaggiano; Donato Rigante; Antonio Vitale; Orso Maria Lucherini; Alessandra Fabbiani; Giovanna Capozio; Chiara Marzo; Viviana Gelardi; Salvatore Grosso; Bruno Frediani; Alessandra Renieri; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2019-12-31       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.